ORN: 144/A amendment for 90,000 common shares

Raymond James & Associates filed an amendment on Form 144/A reporting proposed sales of $1,060,200.00 tied to 90,000 common shares of ORN listed on NYSE.

Rhea-AI Filing Summary

Raymond James & Associates filed an amendment on Form 144/A reporting proposed sales of $1,060,200.00 tied to 90,000 common shares of ORN listed on NYSE.

The filing states the shares were acquired as compensation on 09/12/2022 (RSUs) and identifies the broker and address. The amendment updates prior sale information as of 03/10/2026.

Insights

Equity Capital Markets Analyst

Form 144/A records a broker-mediated resale notice for 90,000 ORN shares.

The filing lists 90,000 common shares and an aggregate dollar amount of $1,060,200.00, reflecting proposed disposition by a broker, Raymond James & Associates. The shares are described as issued for compensation (RSUs) on 09/12/2022.

Cash-flow treatment and planned sale mechanics are not detailed in the excerpt; subsequent trading depends on holder/broker execution and any sale limitations disclosed elsewhere.

Compliance & Disclosure Expert

This amendment updates previously reported resale details and broker contact info.

Form 144/A amendments typically correct or supplement earlier sale notices; this entry supplies broker name, address, and the amended numeric values including 90,000 shares and $1,060,200.00. The filing date shown is 03/10/2026.

Regulatory significance is procedural: it documents the proposed disposition; any legal or lock-up constraints are not disclosed in the provided excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ORN's Form 144/A disclose about the shares?

The amendment discloses a proposed sale of 90,000 common shares of ORN for an aggregate of $1,060,200.00. It notes the shares were acquired as RSU compensation on 09/12/2022.

Who is the broker listed on the ORN 144/A amendment?

The broker named is Raymond James & Associates with an address at 880 Carillon Parkway, St. Petersburg, FL. The filing provides the broker contact information as part of the amendment.

Does the Form 144/A state when the ORN shares will be sold?

The excerpt shows an amendment date of 03/10/2026 but does not specify exact sale execution timing. The filing updates proposed resale details rather than listing firm trade dates.

Were the ORN shares acquired or purchased by the filer?

The filing states the 90,000 shares were acquired as compensation (RSUs) on 09/12/2022. The entry classifies the acquisition source as compensation.

Does the Form 144/A indicate who receives proceeds from the sale?

The provided excerpt does not specify proceeds recipients. The form lists the proposed resale and broker details; it does not state whether proceeds go to the issuer or selling holder in this excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 09:46 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK	0001221430
Filer CCC	XXXXXXXX
Previous Accession Number Of The Filing	0001974078-26-000102
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer	Orion Group Holdings Inc
SEC File Number	001-33891
Address of Issuer	2940 RIVERBY ROAD SUITE 400 Houston TEXAS 77020
Phone	713-852-6500
Name of Person for Whose Account the Securities are To Be Sold	SHANFELTER AUSTIN J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	90000	1060200.00	40083300	03/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/12/2022	Acquired as Compensation - RSU	Issuer			90000	09/12/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks
Date of Notice	03/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Maressia Rooks-Bailey, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Austin J. Shanfelter
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)